Author page: Kathrin Folkendt

FemTec Health Launches Its DTC Brand Awesome Woman to Personalize and Transform the Healthcare Experience for Women

A couple of months ago FemTec Health first made the news, when it came out of stealth with a big vision for the future of women’s health, more than $38M in fresh funding and a leadership team of industry veterans that includes Livongo co-founder Dr. Kimon Angelides, Dr. Kimberly Capone, previously Head of Microbiome Platform at Johnson & Johnson, and Dr. Laura…

Marketing Sexual Health Solutions in Times of Ad Bans and Stigmatization: An Interview with wisp’s Head of Brand Jennifer Dwork

About two weeks ago the femtech world was in uproar yet again as the New York Times article “Why did Facebook reject those ads?” brought attention to the difficulties around advertising faced by many companies in the women’s and sexual health space. This most recent discussion was triggered by a new report released by the Center for Intimacy Justice (CIJ), a nonprofit…

Beyond the Hype: Clue’s Evolution and Reflections on the State of Femtech in 2022

It’s been a couple of exciting months at Clue. Co-founder and femtech pioneer Ida Tin stepped down as CEO, the company received FDA clearance for its digital contraceptive Clue Birth Control and last December a new €16M round of funding to take the new product to market in the U.S. was announced. This post is about Clue, but also about the rise…

Biotech: All Eyes on Ovarian Health and Biology

Ovarian biology is getting quite a bit of attention lately. And rightfully so given the large potential impact innovation in this space can have on the lives of literally every single woman on this planet. So it truly is about time we spend some time on ovarian health here on this blog, share an overview and some insights into the space with…

Celmatix, Evotec & Bayer Just Hit Another Milestone in Their Quest to Develop a First-in-Class Drug for PCOS

Celmatix, a New York-based pre-clinical stage biotech company focused on ovarian biology, has announced today that a novel PCOS target identified as part of its five-year, multi-target alliance with Evotec, has progressed into hit-identification. It may still be early in the process, but what this milestone essentially means is that Celmatix, Evotec and pharma leader Bayer, who formed a “PCOS alliance” around…

A Visit to Procter & Gamble’s (Seemingly All Male) Metaverse

A couple of months ago I got my first Oculus and *really* got into Beat Saber. And while I still do enjoy the occasional VR gaming experience, lately I’ve become even more aware of and excited about the opportunities the Metaverse has to offer beyond gaming (Also in healthcare! More on that soon!) and I was quite intrigued when I saw the…

The Lowdown’s New Missed Contraceptive Pill Calculator and a Somewhat Personal Birth Control Storytime

A few years ago I was a young-ish tech exec working for a U.S. startup. I was based in Europe, traveling to the U.S on a monthly basis and dating someone who lived in Canada. And at the time the birth control pill was my contraceptive of choice. With many hours spent on transatlantic flights, in different timezones and with a body…

Opinion: Is French President Emmanuel Macron the Unlikely Femtech Hero We’ve All Been Waiting For?

Bonjour, mes amis! How’s it going on this beautiful day? Anyone of you spent some time on twitter as of late? Yes? No? Well. If you did and hang out in the femtech & women’s health twitterverse, you may have come across a recent tweet, that turned French President Emmanuel Macron into somewhat of a.. *taking a deep breath*… FEMTECH ICON. (Yes.…